Skip to content

CARBOMEDICS CARBO-SEAL VALSALVA CP-021Recalls & reported problems

Corcym Srl · Class 3 · Implant

All models of CARBOMEDICS CARBO-SEAL VALSALVA (5)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
2
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 08022057013538), received between Dec 23, 2020 and Dec 23, 2020 — classified as 2 deaths.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Insufficient Device Problem Information2

Patient problems

  • Death2

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • DeathDec 23, 2020Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    ON (B)(6) 2020, A PATIENT UNDERWENT A RE-DO AORTIC VALVE REPLACEMENT TO EXPLANT A DEGENERATED MITROFLOW VALVE (REF (B)(4) AND RECEIVED A CARBOSEAL VALSALVA CP-021. A RIGHT COMMON FEMORAL ARTERY BALLOON PUMP AND A RIGHT SWAN-GANZ CATHETER WERE PLACED AT THE TIME OF THE RE-DO PROCEDURE. THE PATIENT WAS MOVED TO THE ICU IN CRITICAL CONDITIONS. THE PATIENT SLOWLY DETERIORATED ON POD1 REQUIRING MORE INOTROPIC SUPPORT AND VENTILATOR SUPPORT. THE PATIENT PASSED AWAY ON (B)(6) 2020.

    Patient problems: Death

    MAUDE report 11068738 ↗
  • DeathDec 23, 2020Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    ON (B)(6) 2020, A PATIENT UNDERWENT A RE-DO AORTIC VALVE REPLACEMENT TO EXPLANT A DEGENERATED MITROFLOW VALVE ((B)(4)) AND RECEIVED A CARBOSEAL VALSALVA CP-021. A RIGHT COMMON FEMORAL ARTERY BALLOON PUMP AND A RIGHT SWAN-GANZ CATHETER WERE PLACED AT THE TIME OF THE RE-DO PROCEDURE. THE PATIENT WAS MOVED TO THE ICU IN CRITICAL CONDITIONS. THE PATIENT SLOWLY DETERIORATED ON POD1 REQUIRING MORE INOTROPIC SUPPORT AND VENTILATOR SUPPORT. THE PATIENT PASSED AWAY ON (B)(6) 2020.

    Patient problems: Death

    MAUDE report 11068730 ↗

Other HEART-VALVE, MECHANICAL devices

All HEART-VALVE, MECHANICAL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page